We are live on
!
Find out more
PCM
Polaris Capital Management Portfolio holdings
AUM
$1.06B
1-Year Est. Return
40.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$1.06B
AUM Growth
-$161M
(-13%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-27.53%
Top 10 Holdings %
Top 10 Hldgs %
47.74%
Holding
90
New
6
Increased
25
Reduced
42
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$19.5M |
| 2 |
Cytokinetics
CYTK
|
+$19.2M |
| 3 |
Booking.com
BKNG
|
+$19.1M |
| 4 |
SW
Smurfit Westrock
SW
|
+$11.1M |
| 5 |
Itron
ITRI
|
+$1.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$31M |
| 2 |
United Therapeutics
UTHR
|
+$24.3M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$18.9M |
| 4 |
Arrow Electronics
ARW
|
+$18.1M |
| 5 |
Lantheus
LNTH
|
+$17.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.83% |
| 2 | Healthcare | 26.01% |
| 3 | Consumer Discretionary | 12.31% |
| 4 | Materials | 7.54% |
| 5 | Technology | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Popular Inc
BPOP
$10.9B
| $86.9M | 8.19% |
529,241
-118,889
| -18% | -$17.9M |
|
|
2
Jazz Pharmaceuticals
JAZZ
$16.1B
| $79.3M | 7.47% |
328,966
-86,400
| -21% | -$18.9M |
|
|
SW
3
Smurfit Westrock
SW
$23.7B
| $75.7M | 7.13% |
1,635,802
+269,252
| +20% | +$11.1M |
|
4
Linde
LIN
$222B
| $51.7M | 4.88% |
99,716
-24,867
| -20% | -$12.6M |
|
|
5
Lantheus
LNTH
$6.59B
| $47.1M | 4.44% |
424,500
-192,500
| -31% | -$17.9M |
|
|
6
Arrow Electronics
ARW
$10.7B
| $41.8M | 3.93% |
195,700
-90,903
| -32% | -$18.1M |
|
7
CVS Health
CVS
$124B
| $37.8M | 3.56% |
365,200
-152,500
| -29% | -$13.6M |
|
8
JPMorgan Chase
JPM
$962B
| $29.6M | 2.78% |
90,291
-27,261
| -23% | -$8.47M |
|
|
9
United Therapeutics
UTHR
$21B
| $29M | 2.73% |
53,450
-43,200
| -45% | -$24.3M |
|
10
SLM Corp
SLM
$4.98B
| $28M | 2.63% |
1,077,700
-351,400
| -25% | -$7.91M |
|
11
International Bancshares
IBOC
$4.45B
| $24.4M | 2.3% |
321,100
-141,904
| -31% | -$10.3M |
|
12
Marathon Petroleum
MPC
$109B
| $23.9M | 2.25% |
93,482
-62,350
| -40% | -$15.3M |
|
13
Eastman Chemical
EMN
$8.09B
| $22.8M | 2.15% |
340,300
-131,300
| -28% | -$9.6M |
|
|
14
Cytokinetics
CYTK
$10.3B
| $22.7M | 2.14% |
+266,900
| New | +$19.2M |
|
15
Ingredion
INGR
$6.41B
| $21.4M | 2.02% |
226,300
-3,300
| -1% | -$349K |
|
|
WBS
16
DELISTED
Webster Financial
WBS
| $21.1M | 1.99% |
276,538
-215,663
| -44% | -$15.7M |
|
17
Cullen/Frost Bankers
CFR
$10.1B
| $20.6M | 1.94% |
133,300
-70,700
| -35% | -$10M |
|
|
18
Booking.com
BKNG
$147B
| $20M | 1.88% |
+112,010
| New | +$19.1M |
|
19
Nomad Foods
NOMD
$1.61B
| $19.5M | 1.84% |
1,783,500
-319,300
| -15% | -$3.18M |
|
20
Gilead Sciences
GILD
$188B
| $19.4M | 1.82% |
153,300
-98,900
| -39% | -$13M |
|
21
Chubb
CB
$134B
| $18.8M | 1.77% |
55,038
-31,487
| -36% | -$10.3M |
|
22
Allison Transmission
ALSN
$10.6B
| $18.6M | 1.75% |
164,900
-93,700
| -36% | -$11.4M |
|
23
Williams Companies
WMB
$90.6B
| $18.5M | 1.74% |
248,800
-150,100
| -38% | -$11M |
|
24
M&T Bank
MTB
$34.7B
| $18.2M | 1.71% |
76,400
-46,194
| -38% | -$10.1M |
|
25
AbbVie
ABBV
$460B
| $17.9M | 1.69% |
71,264
-45,413
| -39% | -$9.77M |
|
Similar funds
BDP
SAM
CIC
PCI
PTC
RPAM
JSC
NAS
Polaris Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Polaris Capital Management held 90 positions worth $1.06B, down 13% from $1.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Polaris Capital Management withdrew a net $292M in Q2 2026, closing 6 positions and reducing 42 holdings. Its most notable exit was MKS Inc, an estimated $31M position sold in full.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Polaris Capital Management opened a new position in Adobe worth $16.9M.
- Polaris Capital Management's largest Q2 2026 buy was Adobe: 82,200 shares worth $16.9M.
- Polaris Capital Management added most to Smurfit Westrock in Q2 2026, an estimated $11.1M increase.
- Polaris Capital Management's biggest Q2 2026 reduction was United Therapeutics, cutting an estimated $24.3M.
- Polaris Capital Management fully exited MKS Inc in Q2 2026, selling an estimated $31M.
- Polaris Capital Management's ten largest holdings make up 48% of its $1.06B portfolio in Q2 2026.
- Polaris Capital Management opened 6 new positions and closed 6 in Q2 2026.
- Polaris Capital Management's portfolio value fell 13% quarter-over-quarter to $1.06B.
Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.